Tacrolimus Assay Kit

FDA 510(k) K203833 · Shanghai Genext Medical Technology Co., Ltd.

Substantially Equivalent

510(k) numberK203833

Submission

Device name
Tacrolimus Assay Kit
Applicant
Shanghai Genext Medical Technology Co., Ltd.
Shanghai, CN
Received
December 30, 2020
Decision date
January 27, 2023
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
MLM – Enzyme Immunoassay, Tracrolimus
Device class
Class II (moderate risk)
Regulation
21 CFR 862.1678
Specialty
Clinical Chemistry

Other 510(k)s with product code MLM

510(k)DeviceApplicantDecision
K173857Elecsys TacrolimusMLM · Traditional Roche Diagnostics11/06/2018SE
K150168Dimension Tacrolimus Flex® Reagent Cartridge (TAC), Dimension Tacrolimus Calibrator (TAC…MLM · Traditional Siemens Healthcare Diagnostics11/04/2015SE
K123343Thermo Scientific QMS Tacrolimus Assay and CalibratorsMLM · Traditional Microgenics Corp.07/11/2013SE
K070820Architect Tacrolimus: Model 1L77MLM · Traditional Fujirebio Diagnostics,Inc.08/01/2007SE
K063868Masstrak Immunosuppressants KitMLM · Traditional Waters Corporation05/25/2007SE
K060502Dimension Tacr Flex Reagent Cartridge, Model DF107MLM · Traditional Dade Behring, Inc.05/18/2006SE
K060385Emit 2000 Tacrolimus Assay and Sample Pretreatment ReagentMLM · Traditional Dade Behring, Inc.04/06/2006SE
K050206Cedia Tacrolimus AssayMLM · Traditional Microgenics Corp.03/15/2005SE

Questions and answers

When was Tacrolimus Assay Kit cleared by the FDA?

Tacrolimus Assay Kit (K203833) received a 510(k) decision of Substantially Equivalent on January 27, 2023, 758 days after the submission was received.

What is the product code of K203833?

The FDA product code is MLM – Enzyme Immunoassay, Tracrolimus, a Class II (moderate risk) device regulated under 21 CFR 862.1678.